Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia
Author(s) -
Smita Bhatia,
Lindsey Hageman,
Yanjun Chen,
F. Lennie Wong,
Elizabeth L. McQuaid,
Christina L. Duncan,
Leo Mascarenhas,
David R. Freyer,
Nkechi Mba,
Paula Aristizabal,
David Walterhouse,
Glen Lew,
Pamela Kempert,
Thomas B. Russell,
René McNall-Knapp,
Shana Jacobs,
Ha Dang,
Elizabeth A. Raetz,
Mary V. Relling,
Wendy Landier
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.14205
Subject(s) - medicine , mercaptopurine , randomized controlled trial , psychological intervention , intervention (counseling) , clinical trial , physical therapy , pediatrics , nursing
Key Points Question In children with acute lymphoblastic leukemia receiving oral mercaptopurine, can an intervention consisting of education and daily text message reminders to prompt directly supervised therapy result in a higher proportion of patients with mercaptopurine adherence 95% or higher, compared with education alone? Findings In this parallel-group, unblinded, randomized clinical trial including 444 children with acute lymphoblastic leukemia, the proportion of patients with mercaptopurine adherence rates 95% or higher did not differ between the intervention and education groups. In exploratory analyses, children aged 12 years and older with baseline adherence less than 90% had higher mean adherence in the intervention group. Meaning This study provides evidence for limiting future trials to older children with acute lymphoblastic leukemia who have low baseline adherence to oral mercaptopurine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom